Shifa International Hospitals Limited (PSX:SHFA)
437.86
+0.55 (0.13%)
At close: Nov 6, 2026
PSX:SHFA Revenue
Shifa International Hospitals had revenue of 9.30B PKR in the quarter ending September 30, 2026, with 22.15% growth. This brings the company's total for the last twelve months to 33.00B, up 15.72% year-over-year. In the fiscal year ending June 30, 2026, Shifa International Hospitals had annual revenue of 31.32B with 11.98% growth. That makes Shifa International Hospitals the 21,351st largest company in the world by revenue and 130th in Pakistan.
Revenue (ttm)
33.00B
Revenue Growth
+15.72%
P/S Ratio
0.84
Revenue / Employee
4.52M
Employees
7,296
Market Cap
27.71B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 31.32B | 3.35B | 11.98% |
| Jun 30, 2025 | 27.97B | 4.41B | 18.74% |
| Jun 30, 2024 | 23.55B | 3.85B | 19.57% |
| Jun 30, 2023 | 19.70B | 3.51B | 21.66% |
| Jun 30, 2022 | 16.19B | 1.97B | 13.84% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 77.83B |
| GlaxoSmithKline Pakistan | 69.53B |
| The Searle Company | 38.29B |
| Highnoon Laboratories | 28.89B |
| AGP Limited | 26.52B |
| Ferozsons Laboratories | 25.09B |
| Citi Pharma | 14.22B |
| Macter International | 12.50B |